196 related articles for article (PubMed ID: 23111625)
1. Target organ damage assessment in French hypertensive patients without established cardiovascular or renal disease: results of the PREVENT-A study.
Rossignol P; Hosseini K; Tropeano AI; Fay R; Tsatsaris A; Guillemin F; Mounier-Vehier C
J Hypertens; 2013 Jan; 31(1):177-85. PubMed ID: 23111625
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular risk stratification according to the 2003 ESH-ESC guidelines in uncomplicated patients with essential hypertension: comparison with the 1999 WHO/ISH guidelines criteria.
Cuspidi C; Meani S; Salerno M; Severgnini B; Fusi V; Valerio C; Catini E; Magrini F; Zanchetti A
Blood Press; 2004; 13(3):144-51. PubMed ID: 15223722
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular risk assessment in hypertensive patients with tests recommended by the European Guidelines on Hypertension.
Gómez-Marcos MA; González-Elena LJ; Recio-Rodríguez JI; Rodríguez-Sánchez E; Magallón-Botaya R; Muñoz-Moreno MF; Patino-Alonso MC; García-Ortiz L
Eur J Prev Cardiol; 2012 Jun; 19(3):515-22. PubMed ID: 21450575
[TBL] [Abstract][Full Text] [Related]
4. Why is cardiovascular risk stratification important in hypertensive patients?
Coll-De-Tuero G; Saez M; Rodriguez-Poncelas A; Barceló-Rado A; Vargas-Vila S; Garre-Olmo J; Sala V; Sieira A; Gelada E; Gelado-Ferrero J
Blood Press; 2012 Jun; 21(3):182-90. PubMed ID: 22486493
[TBL] [Abstract][Full Text] [Related]
5. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
[TBL] [Abstract][Full Text] [Related]
6. Association of renal resistive index with target organ damage in essential hypertension.
Doi Y; Iwashima Y; Yoshihara F; Kamide K; Takata H; Fujii T; Kubota Y; Nakamura S; Horio T; Kawano Y
Am J Hypertens; 2012 Dec; 25(12):1292-8. PubMed ID: 22874890
[TBL] [Abstract][Full Text] [Related]
7. Global risk stratification in primary hypertension: the role of the kidney.
Leoncini G; Ratto E; Viazzi F; Conti N; Falqui V; Parodi A; Tomolillo C; Deferrari G; Pontremoli R
J Hypertens; 2008 Mar; 26(3):427-32. PubMed ID: 18300851
[TBL] [Abstract][Full Text] [Related]
8. Association of tumor necrosis factor-alpha with early target organ damage in newly diagnosed patients with essential hypertension.
Navarro-González JF; Mora C; Muros M; Jarque A; Herrera H; García J
J Hypertens; 2008 Nov; 26(11):2168-75. PubMed ID: 18854757
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of optic fundus examination with retinography in initial evaluation of hypertensive patients.
Foguet Q; Rodríguez A; Saez M; Ubieto A; Beltrán M; Barceló MA; Coll G;
Am J Hypertens; 2008 Apr; 21(4):400-5. PubMed ID: 18369359
[TBL] [Abstract][Full Text] [Related]
10. Left ventricular hypertrophy and cardiovascular risk stratification: impact and cost-effectiveness of echocardiography in recently diagnosed essential hypertensives.
Cuspidi C; Meani S; Valerio C; Fusi V; Sala C; Zanchetti A
J Hypertens; 2006 Aug; 24(8):1671-7. PubMed ID: 16877972
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and correlates of multiple organ damage in a never-treated hypertensive population: role of ambulatory blood pressure.
Cuspidi C; Valerio C; Sala C; Esposito A; Masaidi M; Negri F; Zanchetti A; Mancia G
Blood Press Monit; 2008 Feb; 13(1):7-13. PubMed ID: 18199918
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and correlates of advanced retinopathy in a large selected hypertensive population. The Evaluation of Target Organ Damage in Hypertension (ETODH) study.
Cuspidi C; Meani S; Valerio C; Fusi V; Catini E; Sala C; Magrini F; Zanchetti A
Blood Press; 2005; 14(1):25-31. PubMed ID: 15823944
[TBL] [Abstract][Full Text] [Related]
13. Thresholds for pulse wave velocity, urine albumin creatinine ratio and left ventricular mass index using SCORE, Framingham and ESH/ESC risk charts.
Sehestedt T; Jeppesen J; Hansen TW; Rasmussen S; Wachtell K; Ibsen H; Torp-Pedersen C; Olsen MH
J Hypertens; 2012 Oct; 30(10):1928-36. PubMed ID: 22871892
[TBL] [Abstract][Full Text] [Related]
14. Clustering of target organ damage increases mortality after acute coronary syndromes in patients with arterial hypertension.
Cordero A; Morillas P; Bertomeu-Gonzalez V; Quiles J; Mazón P; Guindo J; Soria F; Llácer A; Lekuona I; Gonzalez-Juanatey JR; Bertomeu V;
J Hum Hypertens; 2011 Oct; 25(10):600-7. PubMed ID: 21160527
[TBL] [Abstract][Full Text] [Related]
15. Target organ damage among hypertensive adults in rural Nigeria: a cross-sectional study.
Nelissen HE; Hendriks ME; Wit FW; Bolarinwa OA; Osagbemi GK; Bindraban NR; Lange JM; Akande TM; Schultsz C; Brewster LM
J Hypertens; 2014 Mar; 32(3):487-94. PubMed ID: 24299916
[TBL] [Abstract][Full Text] [Related]
16. Blood pressure load, vascular permeability and target organ damage in primary hypertension.
Falqui V; Viazzi F; Leoncini G; Ratto E; Parodi A; Conti N; Tomolillo C; Deferrari G; Pontremoli R
J Nephrol; 2007; 20 Suppl 12():S63-7. PubMed ID: 18050146
[TBL] [Abstract][Full Text] [Related]
17. [Incidence and risk factors of target organ damage in 17, 682 elderly hypertensive inpatients between 1993 and 2008].
Cui H; Fan L; Zhang M; Ye P; Dai W; Liu GS
Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Apr; 40(4):307-12. PubMed ID: 22801309
[TBL] [Abstract][Full Text] [Related]
18. Target organ damage and associated clinical conditions among Nigerians with treated hypertension.
Ayodele OE; Alebiosu CO; Salako BL; Awoden OG; Abigun AD
Cardiovasc J S Afr; 2005; 16(2):89-93. PubMed ID: 15915275
[TBL] [Abstract][Full Text] [Related]
19. ESH-ESC guidelines for the management of hypertension.
Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular risk profile and risk stratification of the hypertensive population attended by general practitioners and specialists in Spain. The CONTROLRISK study.
Barrios V; Escobar C; Calderón A; Echarri R; González-Pedel V; Ruilope LM;
J Hum Hypertens; 2007 Jun; 21(6):479-85. PubMed ID: 17314997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
